Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

GastroEsophageal Cancer 1

Interventions

Oxaliplatin 86 Bevacizumab 66 Capecitabine 65 Fluorouracil 48 tislelizumab 41 Gemcitabine 40 Drug Therapy 39 Leucovorin 38 sintilimab 35 Irinotecan 34 lenvatinib 27 Cisplatin 27 HMPL-013 25 S 1 (combination) 23 camrelizumab 22 Immune Checkpoint Inhibitors 21 irinotecan sucrosofate 20 apatinib 20 Surgical Procedures, Operative 20 Radiotherapy 20 Injections 20 130-nm albumin-bound paclitaxel 20 toripalimab 19 Paclitaxel 18 Folfox protocol 17 pembrolizumab 15 Immunotherapy 15 Cetuximab 15 Specimen Handling 14 regorafenib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × bemarituzumab × Gastrointestinal × Clear all

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡